Craft

Balaxi Pharmaceuticals

Stock Price

₹437.3

2023-11-01

Market Capitalization

₹4.4 B

2023-11-01

Revenue

₹3.4 B

FY, 2023

Balaxi Pharmaceuticals Summary

Company Summary

Overview
Balaxi Pharmaceuticals is a company that manufactures pharmaceutical and Fast-moving consumer goods (FCMG) products. It offers salt biscuits, cream-filled biscuits, generic medicines, oral healthcare products, etc.
Type
Public
Status
Active
Founded
2004
Website
http://www.balaxiventures.in
Cybersecurity rating
Sectors

Table of Contents

Balaxi Pharmaceuticals Financials

Summary Financials

Revenue (Q1, 2024)
₹659.6M
Gross profit (Q1, 2024)
₹246.3M
Net income (Q1, 2024)
(₹413.4M)
Cash (FY, 2023)
₹282.2M
EBIT (Q1, 2024)
(₹391.2M)
Enterprise value
$4.3B

Footer menu